Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$2.54M Sell
31,420
-15,035
-32% -$1.23M 2.53% 18
2023
Q1
$3.75M Buy
46,455
+5,265
+13% +$424K 2.72% 17
2022
Q4
$3.08M Sell
41,190
-120
-0.3% -$8.55K 2.74% 15
2022
Q3
$2.67M Buy
41,310
+2,265
+6% +$157K 2.47% 16
2022
Q2
$2.71M Hold
39,045
2.45% 17
2022
Q1
$3M Buy
39,045
+7,320
+23% +$526K 2.14% 22
2021
Q4
$2.43M Buy
31,725
+780
+3% +$57.3K 1.59% 34
2021
Q3
$2.29M Buy
30,945
+7,080
+30% +$531K 1.56% 35
2021
Q2
$1.59M Buy
23,865
+10
+0% +$669 1.06% 39
2021
Q1
$1.77M Buy
23,855
+1,815
+8% +$138K 1.2% 41
2020
Q4
$1.6M Buy
+22,040
New +$1.56M 1.11% 40

Other funds holding HOLX

Mark J. Bradley's HOLX Position: Q2 2023 in Review

Mark J. Bradley reduced its Hologic (HOLX) stake by 32% in Q2 2023, selling an estimated $1.23M and leaving 31,420 shares worth $2.54M. The position accounts for 2.53% of the portfolio, ranked #18.

Mark J. Bradley first reported a position in HOLX in Q4 2020 and has held it in 11 quarters since. The position peaked at $3.75M in Q1 2023. 712 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Mark J. Bradley held 31,420 shares of Hologic worth $2.54M as of Q2 2023.
  • Mark J. Bradley sold 15,035 Hologic shares in Q2 2023, an estimated $1.23M.
  • Hologic made up 2.53% of Mark J. Bradley's portfolio in Q2 2023, its #18 holding.
  • Mark J. Bradley first reported a position in Hologic in Q4 2020 and has held it in 11 quarters since.
  • Mark J. Bradley's Hologic position peaked at $3.75M in Q1 2023.
  • 712 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Mark J. Bradley's 13F filing for Q2 2023, filed 7 Aug 2023.